Osivax
Osivax is a France-based biopharmaceutical company that develops and commercializes T cell-based immunotherapies for the treatment of cancer.
Business Model:
Revenue: $5.5M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Osivax Information
Geographic Data
Address: 70 Rue Saint Jean Dieu
City: Lyon
State: auvergne
Zip: 69007
Country: FR
Financial Info
Stage:
grant
Raised Last:
$11M
Raised Total:$57M
Social
Metrics
5,927,222Website Global Rank
1,392Website Monthly Traffic
Twitter Followers
Description
Osivax is a France-based biopharmaceutical company that develops and commercializes T cell-based immunotherapies for the treatment of cancer.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2022 | Grant | 1 | $10.5M |
Bpifrance Bpifrance |
7/2019 | Series A | $9M |
Noshaq Anaxago |
6/2017 | Seed Round | 1 | $3M |
Anaxago Anaxago |
7/2020 | Series B | 2 | $17M |
Anaxago European Innovation Council Anaxago European Innovation Council |
6/2022 | Grant | $10.5M |
Bpifrance |
7/2020 | Grant | 2 | $17.1M |
Bpifrance European Innovation Council Bpifrance European Innovation Council |
7/2019 | Series A | 3 | $9M |
Anaxago Cédric Delorme Meusinvest (Noshaq) Anaxago Cédric Delorme Meusinvest (Noshaq) |
7/2020 | Series B | $2.8M | 7/2020 | Grant | $34M |
Bpifrance |
6/2017 | Seed | $3M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
